Clinical trial
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With…
NCT00059826 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00059826 |
|---|---|
| Title | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer |
| Official title | A Phase II Study of Interferon-Based Adjuvant Chemoradiation in Patients With Resected Pancreatic Adenocarcinoma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | interferon-alfa-2b, cisplatin, 5-fluorouracil, radiation therapy |
| Enrollment | 89 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Feb 1, 2011 |
| First posted | May 7, 2003 |
| Last update posted | Dec 7, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: